logo

Replimune Group Inc. (REPL)



Trade REPL now with
  Date
  Headline
1/5/2021 8:25:30 AM Replimune Doses First Patient In Phase 1 Clinical Trial Of RP3
10/22/2020 1:10:48 AM Replimune Prices Public Offering Of 4.69 Mln Shares At $40/Shr
7/22/2020 7:22:19 AM Replimune Appoints Andrea Pirzkall As Chief Medical Officer, Effective August 31, 2020
6/3/2020 7:21:39 AM Replimune Q4 Net Loss $15.8 Mln Vs Net Loss $6.7 Mln Last Year
4/24/2019 9:36:27 PM Wedbush Starts Replimune Group Inc. (REPL) At Outperform With $24 Price Target